UPDATE: Goldman Sachs Downgrades Seres Therapeutics (MCRB) to Sell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: MCRB) | Delayed: 2.09 +0.13 (6.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.96 | 52 Week High | $44.51 | |||
| Open | $1.99 | 52 Week Low | $8.05 | |||
| Day High | $2.14 | P/E | N/A | |||
| Day Low | $1.76 | EPS | $0.00 | |||
| Volume | 94,992 | |||||
